South Korea · Delayed Price · Currency is KRW Kolon Life Science Statistics
Total Valuation
KOSDAQ:102940 has a market cap or net worth of KRW 435.44 billion. The enterprise value is 548.84 billion.
| Market Cap | 435.44B |
| Enterprise Value | 548.84B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:102940 has 12.42 million shares outstanding. The number of shares has increased by 8.57% in one year.
| Current Share Class | 12.42M |
| Shares Outstanding | 12.42M |
| Shares Change (YoY) | +8.57% |
| Shares Change (QoQ) | -22.55% |
| Owned by Insiders (%) | 18.06% |
| Owned by Institutions (%) | 0.24% |
| Float | 6.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.41 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 25.98 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.12 |
| EV / Sales | 3.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -80.75 |
Financial Position
The company has a current ratio of 0.50, with a Debt / Equity ratio of 0.47.
| Current Ratio | 0.50 |
| Quick Ratio | 0.25 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -19.28 |
| Interest Coverage | -1.39 |
Financial Efficiency
Return on equity (ROE) is -10.02% and return on invested capital (ROIC) is -2.06%.
| Return on Equity (ROE) | -10.02% |
| Return on Assets (ROA) | -1.44% |
| Return on Invested Capital (ROIC) | -2.06% |
| Return on Capital Employed (ROCE) | -2.93% |
| Revenue Per Employee | 424.88M |
| Profits Per Employee | -47.61M |
| Employee Count | 425 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 3.05 |
Taxes
In the past 12 months, KOSDAQ:102940 has paid 329.17 million in taxes.
| Income Tax | 329.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +84.77% in the last 52 weeks. The beta is -0.11, so KOSDAQ:102940's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | +84.77% |
| 50-Day Moving Average | 31,982.00 |
| 200-Day Moving Average | 28,051.30 |
| Relative Strength Index (RSI) | 65.52 |
| Average Volume (20 Days) | 35,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:102940 had revenue of KRW 180.57 billion and -20.24 billion in losses. Loss per share was -1,629.22.
| Revenue | 180.57B |
| Gross Profit | 27.65B |
| Operating Income | -10.86B |
| Pretax Income | -19.91B |
| Net Income | -20.24B |
| EBITDA | -1.44B |
| EBIT | -10.86B |
| Loss Per Share | -1,629.22 |
Balance Sheet
The company has 17.60 billion in cash and 131.00 billion in debt, giving a net cash position of -113.40 billion or -9,128.23 per share.
| Cash & Cash Equivalents | 17.60B |
| Total Debt | 131.00B |
| Net Cash | -113.40B |
| Net Cash Per Share | -9,128.23 |
| Equity (Book Value) | 276.14B |
| Book Value Per Share | 22,227.17 |
| Working Capital | -109.07B |
Cash Flow
In the last 12 months, operating cash flow was 16.76 billion and capital expenditures -23.56 billion, giving a free cash flow of -6.80 billion.
| Operating Cash Flow | 16.76B |
| Capital Expenditures | -23.56B |
| Free Cash Flow | -6.80B |
| FCF Per Share | -547.07 |
Margins
Gross margin is 15.31%, with operating and profit margins of -6.01% and -11.21%.
| Gross Margin | 15.31% |
| Operating Margin | -6.01% |
| Pretax Margin | -11.02% |
| Profit Margin | -11.21% |
| EBITDA Margin | -0.80% |
| EBIT Margin | -6.01% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:102940 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.57% |
| Shareholder Yield | n/a |
| Earnings Yield | -4.65% |
| FCF Yield | -1.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KOSDAQ:102940 has an Altman Z-Score of 0.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.07 |
| Piotroski F-Score | 3 |